SI
IONS icon

Stephens Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Stephens Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,761
Closed -$91.4K – 1364
2026
Q1 		$91.4K Buy
+26,761
New +$2.11M ﹤0.01% 1251
2024
Q3 		– Sell
-5,138
Closed -$245K – 1319
2024
Q2 		$245K Sell
5,138
-2,715
-35% -$111K ﹤0.01% 1084
2024
Q1 		$340K Sell
7,853
-102
-1% -$4.86K 0.01% 959
2023
Q4 		$402K Buy
7,955
+470
+6% +$22.5K 0.01% 830
2023
Q3 		$340K Sell
7,485
-21
-0.3% -$866 0.01% 865
2023
Q2 		$308K Buy
7,506
+164
+2% +$6.3K 0.01% 904
2023
Q1 		$262K Buy
7,342
+339
+5% +$12.7K 0.01% 935
2022
Q4 		$265K Sell
7,003
-2,122
-23% -$89.3K 0.01% 899
2022
Q3 		$404K Sell
9,125
-2,519
-22% -$106K 0.01% 780
2022
Q2 		$431K Sell
11,644
-908
-7% -$34.2K 0.01% 775
2022
Q1 		$465K Sell
12,552
-5,149
-29% -$169K 0.01% 839
2021
Q4 		$539K Sell
17,701
-3,440
-16% -$108K 0.01% 825
2021
Q3 		$709K Sell
21,141
-4,497
-18% -$169K 0.01% 749
2021
Q2 		$1.02M Buy
25,638
+482
+2% +$18.9K 0.02% 654
2021
Q1 		$1.13M Sell
25,156
-953
-4% -$53.1K 0.02% 588
2020
Q4 		$1.48M Buy
26,109
+4,711
+22% +$235K 0.03% 494
2020
Q3 		$1.01M Sell
21,398
-230
-1% -$12.8K 0.02% 551
2020
Q2 		$1.27M Sell
21,628
-683
-3% -$38K 0.03% 459
2020
Q1 		$1.05M Sell
22,311
-728
-3% -$40.6K 0.03% 456
2019
Q4 		$1.39M Buy
23,039
+1,170
+5% +$69.7K 0.03% 478
2019
Q3 		$1.31M Sell
21,869
-525
-2% -$34.2K 0.03% 487
2019
Q2 		$1.44M Buy
22,394
+846
+4% +$59.8K 0.03% 474
2019
Q1 		$1.75M Sell
21,548
-803
-4% -$51.8K 0.04% 428
2018
Q4 		$1.21M Sell
22,351
-447
-2% -$22.8K 0.03% 473
2018
Q3 		$1.18M Buy
+22,798
New +$1.07M 0.03% 528

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Stephens Inc's IONS Position: Q2 2026 in Review

Stephens Inc sold out of Ionis Pharmaceuticals (IONS) in Q2 2026, closing a stake of 26,761 shares — an estimated $91.4K sold.

Stephens Inc first reported a position in IONS in Q3 2018 and held it in 25 quarters. The position peaked at $1.75M in Q1 2019. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Stephens Inc reported no remaining Ionis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Stephens Inc sold 26,761 Ionis Pharmaceuticals shares in Q2 2026, an estimated $91.4K.
  • Stephens Inc first reported a position in Ionis Pharmaceuticals in Q3 2018 and held it in 25 quarters.
  • Stephens Inc's Ionis Pharmaceuticals position peaked at $1.75M in Q1 2019.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.